Tumor-killing nanoreactors fueled by tumor debris can enhance radiofrequency ablation therapy and boost antitumor immune responses
Radiofrequency ablation (RFA) is clinically adopted to destruct solid tumors, but is often
incapable of completely ablating large tumors and those with multiple metastatic sites. Here …
incapable of completely ablating large tumors and those with multiple metastatic sites. Here …